BeyondSpring Inc. 7,500,000 Ordinary Shares (Par Value $0.0001 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • November 23rd, 2020 • BeyondSpring Inc. • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • May 22nd, 2019 • BeyondSpring Inc. • Pharmaceutical preparations • New York
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This Amended and Restated Employment Agreement (“Agreement”) is entered into on November 10, 2016 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Dr. Lan Huang (“Employee”) (collectively, the “Parties”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 12th, 2024 • BeyondSpring Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (as may be amended, modified, or supplemented from time to time, this “Agreement”) is made and entered into as of June 12, 2024, by and between BeyondSpring Inc., an exempt company with limited liability organized under the laws of the Cayman Islands (the “Company”) and Quanqi Song (the “Purchaser”).
BeyondSpring Inc. Underwriting AgreementUnderwriting Agreement • July 19th, 2019 • BeyondSpring Inc. • Pharmaceutical preparations • New York
RE: BeyondSpring Inc. Director AgreementDirector Agreement • July 24th, 2020 • BeyondSpring Inc. • Pharmaceutical preparations • New York
Capital Increase AgreementCapital Increase Agreement • July 10th, 2019 • BeyondSpring Inc. • Pharmaceutical preparations
This capital increase agreement (hereinafter referred to as the “Agreement”) is entered into by and among following parties on July 3, 2019.
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • June 23rd, 2020 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This SHARE SUBSCRIPTION AGREEMENT (this “Agreement”) is entered into as of June 18, 2020, by and among BeyondSpring Inc., a Cayman Islands company (the “Company”), Decheng Capital China Life Sciences USD Fund II, L.P., a Cayman Islands exempted limited partnership, and Decheng Capital China Life Sciences USD Fund III, L.P., a Cayman Islands exempted limited partnership (collectively, the “Investors”).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
This Second Amendment to Employment Agreement (this “Second Amendment”) is entered into on January 11, 2022 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Dr. Lan Huang (“Employee”) (collectively, the “Parties”).
Sixteenth Amendment to Consulting AgreementConsulting Agreement • April 29th, 2024 • BeyondSpring Inc. • Pharmaceutical preparations
This Sixteenth Amendment ("Amendment") to Consulting Agreement is effective as of July 01st, 2023 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA ("BeyondSpring").
Re: BPI-004 Milestone Stock Bonus AwardBpi-004 Milestone Stock Bonus Award • April 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations
On behalf of BeyondSpring Inc. (the “Company”), I am pleased to offer you a bonus opportunity, granted pursuant to the BeyondSpring Inc. 2017 Omnibus Incentive Plan (the “Plan”), on the terms and conditions set forth in this letter agreement (this “Agreement”) and in the Plan. Capitalized terms used but not otherwise defined in this Agreement are defined in the Plan.
FORM OF SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • February 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This SHARE SUBSCRIPTION AGREEMENT (this “Agreement”) is entered into as of [●], 2017, by and between BeyondSpring Inc., a Cayman Islands company (the “Company”), and the undersigned (the “Investor”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 30th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This Employment Agreement ("Agreement") is entered into this on June 16, 2016 (the "Effective Date") by and between BeyondSpring Pharmaceuticals, Inc. ("Company") and Dr. Gordon Schooley ("Employee") (collectively, the "Parties").
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2020 • BeyondSpring Inc. • Pharmaceutical preparations • York
This Amended and Restated Employment Agreement (the "Agreement") is entered into this January I, 2020 (the "Effective Date"), by and between BeyondSpring Pharmaceuticals, Inc. (the "Company") and Mr. James Tonra ("Employee") (collectively, the "Parties").
Re: BPI-002 Milestone Stock Bonus AwardBpi-002 Milestone Stock Bonus Award • April 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations
On behalf of BeyondSpring Inc. (the “Company”), I am pleased to offer you a bonus opportunity, granted pursuant to the BeyondSpring Inc. 2017 Omnibus Incentive Plan (the “Plan”), on the terms and conditions set forth in this letter agreement (this “Agreement”) and in the Plan. Capitalized terms used but not otherwise defined in this Agreement are defined in the Plan.
First Amendment to Consulting AgreementConsulting Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • Maryland
This First Amendment (“Amendment”) to the consulting Agreements signed on June 18, 2013, and is effective as of March 30, 2014 (the “Amendment Date”), and is entered into by and among:
Eighth Amendment to Consulting AgreementConsulting Agreement • April 30th, 2020 • BeyondSpring Inc. • Pharmaceutical preparations • California
This Eighth Amendment (“Amendment”) to Consulting Agreement is effective as of January 1, 2020 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA (“BeyondSpring”).
Fifteenth Amendment to Consulting AgreementConsulting Agreement • April 18th, 2023 • BeyondSpring Inc. • Pharmaceutical preparations
This Fifteenth Amendment ("Amendment") to Consulting Agreement is effective as of January 01st, 2023 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA ("BeyondSpring").
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2020 • BeyondSpring Inc. • Pharmaceutical preparations
The Employment Agreement by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Richard Daly (the “Employee”) dated as of June 8, 2018 (the “Agreement”) is hereby amended , effective as of September 24, 2019, as follows:
Re: Severance Agreement and General ReleaseSeverance Agreement • April 3rd, 2018 • BeyondSpring Inc. • Pharmaceutical preparations • New York
We are interested in resolving cooperatively your separation of employment with BeyondSpring Pharmaceuticals, Inc. (the “Company”), effective February 20, 2018. Toward this end, we propose the following Severance Agreement, which includes a General Release (“the Agreement”).
CONSULTING AGREEMENTConsulting Agreement • April 30th, 2021 • BeyondSpring Inc. • Pharmaceutical preparations • Delaware
THIS CONSULTING AGREEMENT (“Agreement”) dated January 26, 2021 (the “Effective Date”) is made between BeyondSpring Pharmaceuticals, Inc., a corporation organized under the laws of Delaware, having its principal place of business at 28 Liberty Street, 39th Floor, New York, NY 10005 (the “Company”) and Jeffrey Vacirca, having a principal place of business at 460 King St, Suite 200, Charleston, SC 29403 (“Consultant”), for the purpose of setting forth the exclusive terms and conditions by which the Company desires to acquire Consultant’s services on a temporary basis.
Seventeenth Amendment to Consulting AgreementConsulting Agreement • April 29th, 2024 • BeyondSpring Inc. • Pharmaceutical preparations
This Seventeenth Amendment ("Amendment") to Consulting Agreement is effective as of January 01st, 2024 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 100 Campus Drive, West Side, 4th floor, Suite 410, Florham Park, NJ 07932 ("BeyondSpring").
EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2019 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This Employment Agreement (“Agreement”) is entered into this on March 16, 2018 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Mr. James Tonra (“Employee”) (collectively, the “Parties”).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2020 • BeyondSpring Inc. • Pharmaceutical preparations
This Second Amendment to Employment Agreement (this “Amendment”), dated this12/26/19, is entered into by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Mr. Richard Daly (“Employee”).
Severance and Release AgreementSeverance Agreement • April 18th, 2023 • BeyondSpring Inc. • Pharmaceutical preparations
This Severance and Release of Claims Agreement ("Agreement") is entered into by and between BeyondSpring Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 28 Liberty Street, New York, NY 10005 (the "Employer"), and Dr. Ramon Mohanlal, an individual (the "Employee") (collectively the “Parties” and each a “Party”) effective as of the date set forth below.
Capital Increase AgreementCapital Increase Agreement • July 10th, 2019 • BeyondSpring Inc. • Pharmaceutical preparations
This capital increase agreement (hereinafter referred to as the “Agreement”) is entered into by and among following parties on June 14, 2019.
EMPLOYMENT AGREEMENTEmployment Agreement • April 3rd, 2018 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This Employment Agreement (“Agreement”) is entered into this on March 26, 2018 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Mr. Edward Dongheng Liu (“Employee”) (collectively, the “Parties”).
Fourteenth Amendment to Consulting AgreementConsulting Agreement • April 18th, 2023 • BeyondSpring Inc. • Pharmaceutical preparations
This Fourteenth Amendment ("Amendment") to Consulting Agreement is effective as of June 01, 2022 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA ("BeyondSpring").
Tenth Amendment to Consulting AgreementConsulting Agreement • April 30th, 2021 • BeyondSpring Inc. • Pharmaceutical preparations • California
This Tenth Amendment (“Amendment”) to Consulting Agreement is effective as of November 1, 2020 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA (“BeyondSpring”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 30th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This Employment Agreement ("Agreement") is entered into this on March 7, 2016 (the "Effective Date") by and between BeyondSpring Pharmaceuticals, Inc. ("Company") and Mr. Richard Brand ("Employee") (collectively, the "Parties").
TERMINATION AGREEMENT To ASSET PURCHASE AGREEMENTTermination Agreement • November 15th, 2016 • BeyondSpring Inc. • Pharmaceutical preparations • California
This Termination Agreement to Asset Purchase Agreement (this "Agreement") is made and entered into as of February 2, 2015 (the "Effective Date") by and among BeyondSpring Inc., a Cayman Islands exempted company (the "Company"), Dalian Wanchun Biotechnology Co., Ltd. (hereinafter called "Wanchun") and Nereus Pharmaceuticals, Inc. (hereinafter called "Nereus"). In the event that the Company's IPO (as defined below) is not consummated within three (3) years following the Effective Date, the provisions of this Agreement shall not take effect. Each of the Company, Wanchun and Nereus is referred to herein individually as a "party" and collectively as the "parties".
Eighteenth Amendment to Consulting AgreementConsulting Agreement • April 29th, 2024 • BeyondSpring Inc. • Pharmaceutical preparations
This Seventeenth Amendment ("Amendment") to Consulting Agreement is effective as of April 01st, 2024 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 100 Campus Drive, West Side, 4th floor, Suite 410, Florham Park, NJ 07932 ("BeyondSpring").
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
This Second Amendment to Employment Agreement (this "Second Amendment") is entered into on January 11, 2022 (the "Effective Date") by and between BeyondSpring Pharmaceuticals, Inc. ("Company") and Dr. Ramon Mohanlal ("Employee") (collectively, the "Parties").
Thirteenth Amendment to Consulting AgreementConsulting Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations • California
This Thirteenth Amendment ("Amendment") to Consulting Agreement is effective as of January 01, 2022 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA ("BeyondSpring").
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
This Third Amendment to Employment Agreement (this “Amendment”), dated this 12th day of October, 2021 (the "Effective Date"), is entered into by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Mr. Richard Daly ( “Employee”).
